BWL
BMRN icon

Bogart Wealth LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bogart Wealth LLC’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49K Buy
+61
New +$3.34K ﹤0.01% 1310
2021
Q4 		– Sell
-78
Closed -$6.44K – 753
2021
Q3 		$6K Hold
78
– – ﹤0.01% 513
2021
Q2 		$7K Hold
78
– – ﹤0.01% 475
2021
Q1 		$6K Hold
78
– – ﹤0.01% 453
2020
Q4 		$6K Buy
+78
New +$6.18K ﹤0.01% 364

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bogart Wealth LLC's BMRN Position: Q2 2026 in Review

Bogart Wealth LLC opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 61 shares worth $3.49K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Bogart Wealth LLC previously reported a position in BMRN as recently as Q3 2021.

Bogart Wealth LLC first reported a position in BMRN in Q4 2020 and has held it in 5 quarters since. The position peaked at $7K in Q2 2021. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Bogart Wealth LLC held 61 shares of BioMarin Pharmaceuticals worth $3.49K as of Q2 2026.
  • BioMarin Pharmaceuticals was a new Bogart Wealth LLC position in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1310 holding.
  • Bogart Wealth LLC first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
  • Bogart Wealth LLC's BioMarin Pharmaceuticals position peaked at $7K in Q2 2021.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.